Hospital acquired disease testing Market
Hospital acquired disease testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027
- Category : Healthcare
- Format :
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Hospital Acquired Disease Testing Market
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Hospital Acquired Disease Testing Market Analysis and Forecasts, 2017–2027
4.5. Porter’s Five Force Analysis
5. Key Insights
5.1. Disease Prevalence & Incidence Rate globally with key countries
5.2. Technological Advancements
6. Global Hospital Acquired Disease Testing Market Analysis and Forecasts, By Test Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Test Type, 2017–2027
6.3.1. Urinary Tract Infection
6.3.2. Surgical Site
6.3.3. Pneumonia
6.3.4. Bloodstream
6.3.5. MRSA
6.3.6. Others
6.4. Market Attractiveness By Test Type
7. Global Hospital Acquired Disease Testing Market Analysis and Forecasts, By Region
7.1. Key Findings
7.2. Market Value Forecast By Region
7.2.1. North America
7.2.2. Europe
7.2.3. Asia Pacific
7.2.4. Latin America
7.2.5. Middle East & Africa
7.3. Market Attractiveness By Region
8. North America Hospital Acquired Disease Testing Market Analysis and Forecast
8.1. Introduction
8.2. Market Value Forecast By Test Type, 2017–2027
8.2.1. Urinary Tract Infection
8.2.2. Surgical Site
8.2.3. Pneumonia
8.2.4. Bloodstream
8.2.5. MRSA
8.2.6. Others
8.3. Market Value Forecast By Country, 2017–2027
8.3.1. U.S.
8.3.2. Canada
8.4. Market Attractiveness Analysis
8.4.1. By Test Type
8.4.2. By Country
9. Europe Hospital Acquired Disease Testing Market Analysis and Forecast
9.1. Introduction
9.2. Market Value Forecast By Test Type, 2017–2027
9.2.1. Urinary Tract Infection
9.2.2. Surgical Site
9.2.3. Pneumonia
9.2.4. Bloodstream
9.2.5. MRSA
9.2.6. Others
9.3. Market Value Forecast By Country, 2017–2027
9.3.1. Germany
9.3.2. U.K.
9.3.3. France
9.3.4. Spain
9.3.5. Italy
9.3.6. Rest of Europe
9.4. Market Attractiveness Analysis
9.4.1. By Test Type
9.4.2. By Country
10. Asia Pacific Hospital Acquired Disease Testing Market Analysis and Forecast
10.1. Introduction
10.2. Market Value Forecast By Test Type, 2017–2027
10.2.1. Urinary Tract Infection
10.2.2. Surgical Site
10.2.3. Pneumonia
10.2.4. Bloodstream
10.2.5. MRSA
10.2.6. Others
10.3. Market Value Forecast By Country, 2017–2027
10.3.1. China
10.3.2. Japan
10.3.3. India
10.3.4. Australia & New Zealand
10.3.5. Rest of Asia Pacific
10.4. Market Attractiveness Analysis
10.4.1. By Test Type
10.4.2. By Country
11. Latin America Hospital Acquired Disease Testing Market Analysis and Forecast
11.1. Introduction
11.2. Market Value Forecast By Test Type, 2017–2027
11.2.1. Urinary Tract Infection
11.2.2. Surgical Site
11.2.3. Pneumonia
11.2.4. Bloodstream
11.2.5. MRSA
11.2.6. Others
11.3. Market Value Forecast By Country, 2017–2027
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Rest of Latin America
11.4. Market Attractiveness Analysis
11.4.1. By Test Type
11.4.2. By Country
12. Middle East & Africa Hospital Acquired Disease Testing Market Analysis and Forecast
12.1. Introduction
12.2. Market Value Forecast By Test Type, 2017–2027
12.2.1. Urinary Tract Infection
12.2.2. Surgical Site
12.2.3. Pneumonia
12.2.4. Bloodstream
12.2.5. MRSA
12.2.6. Others
12.3. Market Value Forecast By Country, 2017–2027
12.3.1. GCC Countries
12.3.2. South Africa
12.3.3. Rest of Middle East & Africa
12.4. Market Attractiveness Analysis
12.4.1. By Test Type
12.4.2. By Country
13. Competition Landscape
13.1. Abbott Laboratories
13.1.1. Company Overview (HQ, Business Segments, Employee Strength)
13.1.2. Financial Overview
13.1.3. Growth Strategies
13.1.4. SWOT Analysis
13.2. Becton, Dickinson and Company
13.2.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.2. Financial Overview
13.2.3. Growth Strategies
13.2.4. SWOT Analysis
13.3. bioMérieux SA
13.3.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.2. Financial Overview
13.3.3. Growth Strategies
13.3.4. SWOT Analysis
13.4. F. Hoffmann-La Roche Ltd.
13.4.1. Company Overview (HQ, Business Segments, Employee Strength)
13.4.2. Financial Overview
13.4.3. Growth Strategies
13.4.4. SWOT Analysis
13.5. Hologic, Inc.
13.5.1. Company Overview (HQ, Business Segments, Employee Strength)
13.5.2. Financial Overview
13.5.3. Growth Strategies
13.5.4. SWOT Analysis
13.6. Siemens Healthcare
13.6.1. Company Overview (HQ, Business Segments, Employee Strength)
13.6.2. Financial Overview
13.6.3. Growth Strategies
13.6.4. SWOT Analysis
13.7. Diatherix Laboratories, Inc.
13.7.1. Company Overview (HQ, Business Segments, Employee Strength)
13.7.2. Financial Overview
13.7.3. Growth Strategies
13.7.4. SWOT Analysis
13.8. Meridian Bioscience, Inc.
13.8.1. Company Overview (HQ, Business Segments, Employee Strength)
13.8.2. Financial Overview
13.8.3. Growth Strategies
13.8.4. SWOT Analysis
13.9. Thermo Fisher Scientific, Inc.
13.9.1. Company Overview (HQ, Business Segments, Employee Strength)
13.9.2. Financial Overview
13.9.3. Growth Strategies
13.9.4. SWOT Analysis
List of Table
Table 01 Hospital Acquired Disease Testing Market Size (US$ Mn) Forecast, By Test Type, 2019–2027
Table 02 Hospital Acquired Disease Testing Market Size (US$ Mn) Forecast, By Geography, 2019–2027
Table 03 North America Hospital Acquired Disease Testing Market Size (US$ Mn) And Forecast, By Test Type ,2019–2027
Table 04 North America Hospital Acquired Disease Testing Market Size (US$ Mn) And Forecast, By Country ,2019–2027
Table 05 Europe Hospital Acquired Disease Testing Market Size (US$ Mn) And Forecast, By Test Type ,2019–2027
Table 06 Europe Hospital Acquired Disease Testing Market Size (US$ Mn) And Forecast, By Country, 2019–2027
Table 07 Asia Pacific Hospital Acquired Disease Testing Market Size (US$ Mn) And Forecast, By Test Type ,2019–2027
Table 08 Asia Pacific Hospital Acquired Disease Testing Market Size (US$ Mn) And Forecast, By Country ,2019–2027
Table 09 Latin America Hospital Acquired Disease Testing Market Size (US$ Mn) And Forecast, By Test Type ,2019–2027
Table 10 Latin America Hospital Acquired Disease Testing Market Size (US$ Mn) And Forecast, By Country ,2019–2027
Table 11 Middle East & Africa Hospital Acquired Disease Testing Market Size (US$ Mn) And Forecast, By Test Type ,2019–2027
Table 12 Middle East & Africa Hospital Acquired Disease Testing Market Size (US$ Mn) And Forecast, By Country ,2019–2027
List of Figure
Figure 01 Hospital Acquired Disease Testing Market Snapshot
Figure 02 Hospital Acquired Disease Testing Market Size (US$ Mn) And Forecast, 2019–2027
Figure 03 Hospital Acquired Disease Testing Market Attractiveness Analysis By Test Type
Figure 04 Hospital Acquired Disease Testing Market Revenue (US$ Mn) And Y-O-Y Growth (%), North America, 2019–2027
Figure 05 Hospital Acquired Disease Testing Market Revenue (US$ Mn) And Y-O-Y Growth (%),Europe, 2019–2027
Figure 06 Hospital Acquired Disease Testing Market Revenue (US$ Mn) And Y-O-Y Growth (%),Asia Pacific, 2019–2027
Figure 07 Hospital Acquired Disease Testing Market Revenue (US$ Mn) And Y-O-Y Growth (%),Latin America, 2019–2027
Figure 08 Hospital Acquired Disease Testing Market Revenue (US$ Mn) And Y-O-Y Growth (%),Middle East & Africa, 2019–2027
Figure 09 North America Hospital Acquired Disease Testing Value Share Analysis, By Test Type, 2019 And 2027
Figure 10 North America Hospital Acquired Disease Testing Value Share Analysis, By Country, 2019 And 2027
Figure 11 Europe Hospital Acquired Disease Testing Value Share Analysis, By Test Type, 2019 And 2027
Figure 12 Europe Hospital Acquired Disease Testing Value Share Analysis, By Country, 2019 And 2027
Figure 13 Asia Pacific Hospital Acquired Disease Testing Value Share Analysis, By Test Type, 2019 And 2027
Figure 14 Asia Pacific Hospital Acquired Disease Testing Value Share Analysis, By Country, 2019 And 2027
Figure 15 Latin America Hospital Acquired Disease Testing Value Share Analysis, By Test Type, 2019 And 2027
Figure 16 Latin America Hospital Acquired Disease Testing Value Share Analysis, By Country, 2019 And 2027
Figure 17 Middle East & Africa Hospital Acquired Disease Testing Value Share Analysis, By Test Type, 2019 And 2027
Figure 18 Middle East & Africa Hospital Acquired Disease Testing Value Share Analysis, By Country, 2019 And 2027
